129 related articles for article (PubMed ID: 14527906)
1. Progression of gene hypermethylation in gallstone disease leading to gallbladder cancer.
House MG; Wistuba II; Argani P; Guo M; Schulick RD; Hruban RH; Herman JG; Maitra A
Ann Surg Oncol; 2003 Oct; 10(8):882-9. PubMed ID: 14527906
[TBL] [Abstract][Full Text] [Related]
2. Promoter methylation profile in preneoplastic and neoplastic gallbladder lesions.
García P; Manterola C; Araya JC; Villaseca M; Guzmán P; Sanhueza A; Thomas M; Alvarez H; Roa JC
Mol Carcinog; 2009 Jan; 48(1):79-89. PubMed ID: 18543280
[TBL] [Abstract][Full Text] [Related]
3. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis.
Takahashi T; Shivapurkar N; Riquelme E; Shigematsu H; Reddy J; Suzuki M; Miyajima K; Zhou X; Bekele BN; Gazdar AF; Wistuba II
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6126-33. PubMed ID: 15447999
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder.
Roa JC; Roa I; Correa P; Vo Q; Araya JC; Villaseca M; Guzmán P; Schneider BG
J Gastroenterol; 2005 Jan; 40(1):79-86. PubMed ID: 15692793
[TBL] [Abstract][Full Text] [Related]
5. Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.
House MG; Herman JG; Guo MZ; Hooker CM; Schulick RD; Lillemoe KD; Cameron JL; Hruban RH; Maitra A; Yeo CJ
Ann Surg; 2003 Sep; 238(3):423-31; discussion 431-2. PubMed ID: 14501508
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation profile in gallbladder cancer.
Roa JC; Anabalón L; Roa I; Melo A; Araya JC; Tapia O; de Aretxabala X; Muñoz S; Schneider B
J Gastroenterol; 2006 Mar; 41(3):269-75. PubMed ID: 16699861
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease.
Igarashi K; Yamashita K; Katoh H; Kojima K; Ooizumi Y; Nishizawa N; Nishiyama R; Kawamata H; Tajima H; Kaizu T; Kumamoto Y; Watanabe M
PLoS One; 2017; 12(11):e0188178. PubMed ID: 29161283
[TBL] [Abstract][Full Text] [Related]
8. Global and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile.
Kagohara LT; Schussel JL; Subbannayya T; Sahasrabuddhe N; Lebron C; Brait M; Maldonado L; Valle BL; Pirini F; Jahuira M; Lopez J; Letelier P; Brebi-Mieville P; Ili C; Pandey A; Chatterjee A; Sidransky D; Guerrero-Preston R
Future Oncol; 2015; 11(2):233-49. PubMed ID: 25066711
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
[TBL] [Abstract][Full Text] [Related]
10. Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations.
Narayan RR; Creasy JM; Goldman DA; Gönen M; Kandoth C; Kundra R; Solit DB; Askan G; Klimstra DS; Basturk O; Allen PJ; Balachandran VP; D'Angelica MI; DeMatteo RP; Drebin JA; Kingham TP; Simpson AL; Abou-Alfa GK; Harding JJ; O'Reilly EM; Butte JM; Matsuyama R; Endo I; Jarnagin WR
Cancer; 2019 Feb; 125(4):575-585. PubMed ID: 30427539
[TBL] [Abstract][Full Text] [Related]
11. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor gene hypermethylation as a predictor of gastric stromal tumor behavior.
House MG; Guo M; Efron DT; Lillemoe KD; Cameron JL; Syphard JE; Hooker CM; Abraham SC; Montgomery EA; Herman JG; Brock MV
J Gastrointest Surg; 2003 Dec; 7(8):1004-14; discussion 1014. PubMed ID: 14675710
[TBL] [Abstract][Full Text] [Related]
13. Genetic analysis of xanthogranulomatous cholecystitis: precancerous lesion of gallbladder cancer?
Takada M; Horita Y; Okuda S; Okumoto S; Samizo M; Wada T; Kuroda Y; Maeda S
Hepatogastroenterology; 2002; 49(46):935-7. PubMed ID: 12143246
[TBL] [Abstract][Full Text] [Related]
14. Specific patterns of gene methylation in natural killer cell lymphomas : p73 is consistently involved.
Siu LL; Chan JK; Wong KF; Kwong YL
Am J Pathol; 2002 Jan; 160(1):59-66. PubMed ID: 11786399
[TBL] [Abstract][Full Text] [Related]
15. Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas.
House MG; Guo M; Iacobuzio-Donahue C; Herman JG
Carcinogenesis; 2003 Feb; 24(2):193-8. PubMed ID: 12584167
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
17. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
[TBL] [Abstract][Full Text] [Related]
18. Prostate stem cell antigen, a presumable organ-dependent tumor suppressor gene, is down-regulated in gallbladder carcinogenesis.
Ono H; Hiraoka N; Lee YS; Woo SM; Lee WJ; Choi IJ; Saito A; Yanagihara K; Kanai Y; Ohnami S; Chiwaki F; Sasaki H; Sakamoto H; Yoshida T; Saeki N
Genes Chromosomes Cancer; 2012 Jan; 51(1):30-41. PubMed ID: 21936014
[TBL] [Abstract][Full Text] [Related]
19. Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer.
Wang J; Lee JJ; Wang L; Liu DD; Lu C; Fan YH; Hong WK; Mao L
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6119-25. PubMed ID: 15447998
[TBL] [Abstract][Full Text] [Related]
20. WNT inhibitory factor 1 promoter hypermethylation is an early event during gallbladder cancer tumorigenesis that predicts poor survival.
Lin B; Hong H; Jiang X; Li C; Zhu S; Tang N; Wang X; She F; Chen Y
Gene; 2017 Jul; 622():42-49. PubMed ID: 28438695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]